Fate Therapeutics (FATE) Operating Income US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Operating Income, bln rub -100.7 -128.1 -217.0 -308.4 -190.5   -196.6  
Changes by years, y/y, % +50% +27% +69% +42% -38%     +23.2%

Fate Therapeutics. Operating Income, bln rub

Created with Highcharts 6.0.6-13.3-13.3-13.6-13.6-17.7-17.7-24.9-24.9-27.8-27.8-32.0-32.0-42.1-42.1-67.1-67.1-100.7-100.7-128.1-128.1-217.0-217.0-308.4-308.4-190.5-190.5-196.6-196.62011201220132014201520162017201820192020202120222023LTM-350-300-250-200-150-100-500smart-lab.ru

Fate Therapeutics. Operating Income, changes, %

Created with Highcharts 6.0.62.02.030.430.440.940.911.611.615.015.031.831.859.359.350.150.127.227.269.469.442.142.1-38.2-38.23.23.2201220132014201520162017201820192020202120222023LTM-50-250255075smart-lab.ru

Fate Therapeutics. Operating Income, sum by quarters, bln rub

Created with Highcharts 6.0.6-4.0-4.0-4.9-4.9-5.9-5.9-6.9-6.9-7.7-7.7-12.2-12.2-16.7-16.7-29.1-29.1-33.4-33.4-68.6-68.6-64.4-64.4-48.1-48.1-5.1-5.1-6.0-6.0-6.3-6.3-8.4-8.4-10.3-10.3-16.7-16.7-27.1-27.1-31.5-31.5-54.6-54.6-86.4-86.4-51.3-51.3-52.4-52.4-4.3-4.3-6.0-6.0-7.2-7.2-8.0-8.0-9.6-9.6-19.6-19.6-24.1-24.1-28.7-28.7-46.8-46.8-83.1-83.1-62.6-62.6-45.1-45.1-6.9-6.9-7.3-7.3-7.9-7.9-10.0-10.0-14.1-14.1-20.4-20.4-34.5-34.5-46.2-46.2-74.5-74.5-28.6-28.6-51.1-51.14 quarter3 quarter2 quarter1 quarter2012201320142015201620172018201920202021202220232024-350-300-250-200-150-100-500smart-lab.ru

Fate Therapeutics (FATE) Operating Income US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Operating Income, bln rub -51.3 -48.1 -51.1 -45.1 -52.4   -196.6
Changes by years, y/y, % -41% -25% +79% -28% +2%    
Changes by quarters, q/q, % -18% -6% +6% -12% +16%    

Fate Therapeutics. Operating Income, bln rub

Created with Highcharts 6.0.6-4.0-4.0-4.3-4.3-5.1-5.1-4.9-4.9-6.9-6.9-6.0-6.0-6.0-6.0-5.9-5.9-7.3-7.3-7.2-7.2-6.3-6.3-6.9-6.9-7.9-7.9-8.0-8.0-8.4-8.4-7.7-7.7-10.0-10.0-9.6-9.6-10.3-10.3-12.2-12.2-14.1-14.1-19.6-19.6-16.7-16.7-16.7-16.7-20.4-20.4-24.1-24.1-27.1-27.1-29.1-29.1-34.5-34.5-28.7-28.7-31.5-31.5-33.4-33.4-46.2-46.2-46.8-46.8-54.6-54.6-68.6-68.6-74.5-74.5-83.1-83.1-86.4-86.4-64.4-64.4-28.6-28.6-62.6-62.6-51.3-51.3-48.1-48.1-51.1-51.1-45.1-45.1-52.4-52.42012Q42013Q22013Q32013Q42014Q12014Q22014Q32014Q42015Q12015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-100-80-60-40-200smart-lab.ru

Fate Therapeutics. Operating Income, changes, y/y, %

Created with Highcharts 6.0.621.221.241.541.516.216.221.221.25.65.619.519.55.75.716.316.38.18.110.910.932.632.610.710.726.026.019.619.623.323.360.060.040.940.9104.9104.961.461.436.736.745.545.522.822.862.562.573.773.768.768.719.219.216.116.114.914.934.034.063.063.073.573.5105.5105.561.161.177.777.758.258.2-6.1-6.1-61.6-61.6-24.7-24.7-40.6-40.6-25.4-25.478.678.6-27.9-27.92.12.12013Q42014Q22014Q32014Q42015Q12015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-50050100-100150smart-lab.ru

Fate Therapeutics. Operating Income, changes, q/q, %

Created with Highcharts 6.0.65.65.620.620.6-4.8-4.841.541.5-12.9-12.9-0.9-0.9-0.7-0.723.223.2-1.4-1.4-12.3-12.39.29.214.514.51.11.14.84.8-8.8-8.830.330.3-4.0-4.08.08.018.418.414.814.839.539.5-14.9-14.90.30.322.122.117.817.812.612.67.27.218.618.6-16.8-16.89.79.76.16.138.438.41.21.216.816.825.625.68.58.511.611.63.93.9-25.4-25.4-55.6-55.6118.8118.8-18.0-18.0-6.2-6.26.26.2-11.7-11.716.216.22013Q22013Q32013Q42014Q12014Q22014Q32014Q42015Q12015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-100-50050100150smart-lab.ru